ArticleBMC cancer2025

RALOX-HAIC (raltitrexed + oxaliplatin) combined with lenvatinib improves survival and safety in elderly patients with unresectable hepatocellular carcinoma.

Haohao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.